Christine Garnett

3.6k total citations
71 papers, 2.6k citations indexed

About

Christine Garnett is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Christine Garnett has authored 71 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 26 papers in Molecular Biology and 12 papers in Computational Theory and Mathematics. Recurrent topics in Christine Garnett's work include Cardiac electrophysiology and arrhythmias (45 papers), Receptor Mechanisms and Signaling (17 papers) and ECG Monitoring and Analysis (16 papers). Christine Garnett is often cited by papers focused on Cardiac electrophysiology and arrhythmias (45 papers), Receptor Mechanisms and Signaling (17 papers) and ECG Monitoring and Analysis (16 papers). Christine Garnett collaborates with scholars based in United States, United Kingdom and Sweden. Christine Garnett's co-authors include Norman Stockbridge, Christoffer W. Tornøe, Börje Darpö, Yaning Wang, Lars Johannesen, Marek Malík, Jeffry Florian, Philip T. Sager, David G. Strauss and Richard C. Brundage and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Christine Garnett

68 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Garnett United States	27	1.5k	1.1k	288	277	245	71	2.6k
Rashmi R. Shah United Kingdom	33	1.4k 0.9×	1.4k 1.3×	99 0.3×	209 0.8×	608 2.5×	85	3.4k
Börje Darpö United States	30	2.0k 1.3×	1.2k 1.1×	131 0.5×	227 0.8×	170 0.7×	119	3.1k
Ulrich Broeckel United States	37	633 0.4×	1.1k 1.0×	144 0.5×	72 0.3×	293 1.2×	95	3.9k
Yaning Wang United States	29	352 0.2×	769 0.7×	533 1.9×	321 1.2×	591 2.4×	117	3.4k
Christoffer W. Tornøe United States	18	554 0.4×	623 0.6×	230 0.8×	98 0.4×	155 0.6×	29	2.5k
Philip T. Sager United States	40	5.3k 3.5×	1.8k 1.7×	168 0.6×	384 1.4×	368 1.5×	142	7.7k
Rajanikanth Madabushi United States	19	274 0.2×	443 0.4×	277 1.0×	196 0.7×	285 1.2×	58	1.8k
Roland Valdes United States	29	822 0.5×	840 0.8×	84 0.3×	62 0.2×	232 0.9×	77	2.8k
Yu Chen Barrett United States	17	1.3k 0.8×	696 0.6×	83 0.3×	50 0.2×	265 1.1×	25	2.9k
Alexander Staab Germany	23	376 0.2×	445 0.4×	156 0.5×	121 0.4×	541 2.2×	54	2.0k

Countries citing papers authored by Christine Garnett

Since Specialization

Citations

This map shows the geographic impact of Christine Garnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Garnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Garnett more than expected).

Fields of papers citing papers by Christine Garnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Garnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Garnett. The network helps show where Christine Garnett may publish in the future.

Co-authorship network of co-authors of Christine Garnett

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Garnett. A scholar is included among the top collaborators of Christine Garnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Garnett. Christine Garnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Wendy, Moran Choe, Lars Johannesen, et al.. (2023). ICH S7B In Vitro Assays Do Not Address Mechanisms of QT_C Prolongation for Peptides and Proteins – Data in Support of Not Needing Dedicated QT_C Studies. Clinical Pharmacology & Therapeutics. 114(6). 1332–1341. 6 indexed citations

Delisle, Brian P., Alfred L. George, Jeanne M. Nerbonne, et al.. (2021). Understanding Circadian Mechanisms of Sudden Cardiac Death: A Report From the National Heart, Lung, and Blood Institute Workshop, Part 2: Population and Clinical Considerations. Circulation Arrhythmia and Electrophysiology. 14(11). e010190–e010190. 6 indexed citations

Delisle, Brian P., Alfred L. George, Jeanne M. Nerbonne, et al.. (2021). Understanding Circadian Mechanisms of Sudden Cardiac Death: A Report From the National Heart, Lung, and Blood Institute Workshop, Part 1: Basic and Translational Aspects. Circulation Arrhythmia and Electrophysiology. 14(11). e010181–e010181. 8 indexed citations

Scott, Jacqueline V., Christine Garnett, Manreet Kanwar, Norman Stockbridge, & Raymond L. Benza. (2020). Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 203(6). 726–736. 18 indexed citations

Scott, Jacqueline V., Manreet Kanwar, Christine Garnett, Norman Stockbridge, & Raymond L. Benza. (2020). Pulmonary Arterial Registry Risk Algorithms Improve Upon Clinical Trial Enrichment Methodology. A2920–A2920. 1 indexed citations

Malík, Marek, Christine Garnett, Katerina Hnatkova, et al.. (2018). Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes. Journal of Pharmacokinetics and Pharmacodynamics. 45(3). 491–503. 13 indexed citations

Malík, Marek, Christine Garnett, Katerina Hnatkova, et al.. (2018). Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections. Drug Safety. 42(3). 401–414. 10 indexed citations

Garnett, Christine, Peter L. Bonate, Qianyu Dang, et al.. (2017). Scientific white paper on concentration-QTc modeling. Journal of Pharmacokinetics and Pharmacodynamics. 45(3). 383–397. 170 indexed citations

Garnett, Christine, et al.. (2016). Operational Characteristics of Linear Concentration‐QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies. Clinical Pharmacology & Therapeutics. 100(2). 170–178. 34 indexed citations

10.

Johannesen, Lars, Christine Garnett, & Marek Malík. (2014). Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies. Drug Safety. 37(3). 183–189. 6 indexed citations

11.

Stockbridge, Norman, Joel Morganroth, Rashmi R. Shah, & Christine Garnett. (2013). Dealing with Global Safety Issues. Drug Safety. 36(3). 167–182. 121 indexed citations

12.

Johannesen, Lars, José Vicente, Richard A. Gray, et al.. (2013). Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science. Clinical Pharmacology & Therapeutics. 95(5). 501–508. 68 indexed citations

13.

Johannesen, Lars, José Vicente, Loriano Galeotti, et al.. (2012). Abstract 15725: Normal Limits of Variability of Spatial QRS-T Angle and Ventricular Gradient: Analysis of 20 Thorough-QT Studies. Circulation.

14.

Deisseroth, Albert, Edvardas Kaminskas, Joseph A. Grillo, et al.. (2012). U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis. Clinical Cancer Research. 18(12). 3212–3217. 107 indexed citations

15.

Stockbridge, Norman, Joanne Zhang, Christine Garnett, & Marek Malík. (2012). Practice and challenges of thorough QT studies. Journal of Electrocardiology. 45(6). 582–587. 17 indexed citations

16.

Garnett, Christine, Jogarao Gobburu, Venkatesh Atul Bhattaram, et al.. (2011). Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions. Clinical Pharmacokinetics. 50(10). 627–635. 112 indexed citations

17.

Mehrotra, Nitin, et al.. (2011). Role of exposure-response analysis to guide dose selection in pediatric drug development when extrapolating efficacy from adults. Inflammatory Bowel Diseases. 17. S5–S6. 3 indexed citations

18.

Mason, Jay W., et al.. (2010). Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms: Implications for Blinding in Active‐Controlled Cardiac Repolarization Studies. The Journal of Clinical Pharmacology. 50(11). 1249–1259. 24 indexed citations

19.

Zhu, Hao, Yaning Wang, Jogarao Gobburu, & Christine Garnett. (2010). Considerations for Clinical Trial Design and Data Analyses of Thorough QT Studies Using Drug‐Drug Interaction. The Journal of Clinical Pharmacology. 50(10). 1106–1111. 13 indexed citations

20.

Rock, Edwin P., John K. Finkle, Howard Fingert, et al.. (2009). Assessing proarrhythmic potential of drugs when optimal studies are infeasible. American Heart Journal. 157(5). 827–836.e1. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact